Article
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.
Journal of experimental & clinical cancer research : CR - 14 Jul 2010
Jain Lokesh, Sissung Tristan M, Danesi Romano, Kohn Elise C, Dahut William L, Kummar Shivaani, Venzon David, Liewehr David, English Bevin C, Baum Caitlin E, Yarchoan Robert, Giaccone Giuseppe, Venitz Jürgen, Price Douglas K, Figg William D
Abstract excerpt
BACKGROUND: Hypertension (HT) and hand-foot skin reactions (HFSR) may be related to the activity of bevacizumab and sorafenib. We hypothesized that these toxicities would correspond to favorable outcome in these drugs, that HT and HFSR would coincide, and that VEGFR2 genotypic variation would be related to toxicity and clinical outcomes. METHODS: Toxicities (> or = grade 2 HT or HFSR), progression-free survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
